Walgreen Company February Sales Rise 5% to Nearly $6.1 Billion

Although Walgreen said its sales were negatively impacted by the weather in the first quarter, it still noted its sales rose by almost $300 million in the month of February.

Mar 5, 2014 at 2:30PM

Walgreen (NASDAQ:WBA) announced today that February sales were $6.05 billion, which represented a 5% improvement over the $5.76 billion posted in February of 2013. The company said factors including the weather and the introduction of generics held the number down.

In total, comparable-store sales-- a metric measuring sales at stores that have been open for more than a year -- at the drugstore chain were up 4.5% in the month, but the company noted its sales were negatively affected by 0.9 percentage points as a result of generic drugs which were introduced in the previous 12 months. In addition, Walgreen said the lower number of flu incidences reduced comparable sales by an additional 0.4 percentage points in February.

The company said 7.7 million flu shots were administered at pharmacies and clinics in the flu season to date, compared to 7.0 million last year. This helped bump up pharmacy sales numbers.

February sales at comparable Walgreens pharmacies rose by 6.1%, and total pharmacy sales grew by 6.7% year over year. Once more the company highlighted its comparable store sales were affected by generic drug introductions, which resulted in a 1.4-percentage-point reduction in pharmacy sales figures. In addition, the lessened flu incidents negatively affected comparable pharmacy sales by 0.7 percentage points. Pharmacy sales accounted for 62.9% of total sales for the month.

The company said total front-end sales increased 3% year over year.

In total, Walgreen noted it saw sales rise to $19.6 billion for the second quarter of its 2014 fiscal year (December through February), which represented a 5.2% increase over the $18.7 billion seen in the second quarter of 2013. Its comparable-store sales rose 4.5%, but the company highlighted its front-end sales were negatively affected by 0.6 percentage points by severe weather and that prescriptions filled at comparable stores were negatively impacted by 0.8 percentage points because of the weather. In addition Walgreen noted it saw increases in selling, general, and administrative expenses resulting from the severe weather.

The company concluded its release by revealing it has seen its total sales for the first six months of its 2014 fiscal year rise from $36 billion last year to $38 billion this year, an increase of 5.5%.

Patrick Morris has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information